IBSRELA
tenapanor hydrochloride
- Strength
- 53.2 mg/1
- Form
- Tablet
- Class
- Sodium-Hydrogen Exchanger 3 Inhibitor
Ardelyx, Inc.
Not stocked by us — reference only
Tenapanor
Listed by Ardelyx, Inc.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Sodium-Hydrogen Exchanger 3 Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 73154-130 |
| FDA application | NDA213931 |
| RxNorm concept | 2669440 |
| Package sizes listed | 3 |
| Marketed since | October 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
tenapanor hydrochloride
Ardelyx, Inc.
Not stocked by us — reference only
Tenapanor
Ardelyx, Inc.
Not stocked by us — reference only
Tenapanor
Ardelyx, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.